AG˹ٷ

STOCK TITAN

[Form 4] Option Care Health, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Pate R. Carter, a director of Option Care Health, Inc. (OPCH), reported purchasing 750 shares of the company's common stock on 08/20/2025 at a weighted average price of $27.1886 per share. After the reported purchase the filing shows the reporting person beneficially owns 41,910 shares. The transaction is coded "P" (purchase). The explanatory note states the 750 shares were bought in multiple transactions with prices ranging from $27.18 to $27.1899, and the reporter will provide detailed per-trade quantities and prices upon request. The Form 4 was signed on behalf of Mr. Carter by an attorney-in-fact.

Pate R. Carter, amministratore di Option Care Health, Inc. (OPCH), ha comunicato l'acquisto di 750 azioni del capitale sociale della società il 20/08/2025 a un prezzo medio ponderato di $27.1886 per azione. Dopo l'acquisto segnalato, la dichiarazione indica che la persona segnalante detiene beneficiariamente 41.910 azioni. L'operazione è codificata come "P" (acquisto). La nota esplicativa specifica che le 750 azioni sono state acquistate in più operazioni con prezzi compresi tra $27.18 e $27.1899, e che il dichiarante fornirà, su richiesta, le quantità e i prezzi dettagliati per singola transazione. Il Modulo 4 è stato firmato per conto del Sig. Carter da un procuratore.

Pate R. Carter, director de Option Care Health, Inc. (OPCH), informó la compra de 750 acciones de las acciones ordinarias de la compañía el 20/08/2025 a un precio promedio ponderado de $27.1886 por acción. Tras la compra informada, la presentación muestra que la persona informante posee beneficiariamente 41.910 acciones. La operación está codificada como "P" (compra). La nota explicativa indica que las 750 acciones se adquirieron en varias transacciones con precios que oscilan entre $27.18 y $27.1899, y que el informante proporcionará, a petición, las cantidades y precios detallados por operación. El Formulario 4 fue firmado en nombre del Sr. Carter por un apoderado.

Pate R. Carter� Option Care Health, Inc. (OPCH) 이사로서 2025-08-20� 회사 보통� 750�� 주당 가중평� $27.1886� 매수했음� 보고했습니다. 보고� 매수 � 해당 보고인은 41,910�� 실질적으� 보유하고 있는 것으� 기재되어 있습니다. 거래� "P"(매수)� 코드화되� 있습니다. 설명 노트에는 750주가 여러 건의 거래� 매수되었으며 가격은 $27.18에서 $27.1899 사이였�, 요청 � 거래� 수량 � 가격을 상세� 제공하겠다고 명시되어 있습니다. Form 4� 카터 씨를 대신해 법적 대리인� 서명했습니다.

Pate R. Carter, administrateur d'Option Care Health, Inc. (OPCH), a déclaré l'achat de 750 actions ordinaires de la société le 20/08/2025 au prix moyen pondéré de $27.1886 par action. Après l'achat déclaré, le document indique que la personne déclarant détient bénéficiairement 41 910 actions. La transaction est codée "P" (achat). La note explicative précise que les 750 actions ont été acquises en plusieurs opérations aux prix variant de $27.18 à $27.1899, et que le déclarant fournira, sur demande, les quantités et prix détaillés par transaction. Le formulaire 4 a été signé pour M. Carter par un mandataire.

Pate R. Carter, Direktor von Option Care Health, Inc. (OPCH), meldete den Kauf von 750 Aktien der Stammaktien des Unternehmens am 20.08.2025 zu einem gewichteten Durchschnittspreis von $27.1886 je Aktie. Nach dem gemeldeten Erwerb weist die Meldung aus, dass die meldende Person wirtschaftlich 41.910 Aktien besitzt. Die Transaktion ist mit "P" (Kauf) codiert. Die erläuternde Anmerkung besagt, dass die 750 Aktien in mehreren Transaktionen zu Preisen zwischen $27.18 und $27.1899 erworben wurden und der Meldende auf Anfrage detaillierte Mengen und Preise je Trade bereitstellt. Das Formular 4 wurde im Namen von Herrn Carter von einem Bevollmächtigten unterschrieben.

Positive
  • Director purchase disclosed with specific share count and weighted average price, meeting Form 4 disclosure requirements
  • Post-transaction beneficial ownership is reported (41,910 shares), providing transparency
  • Explanatory note details per-trade price range and offers to provide full per-trade information on request
Negative
  • None.

Insights

TL;DR: Director purchased 750 shares, modest insider buy; no material change to ownership.

The filing documents a standard Section 16 purchase by a director: 750 shares acquired at a weighted average of $27.1886 on 08/20/2025, bringing beneficial ownership to 41,910 shares. This is a routine disclosure required under Form 4 and does not include derivative transactions or other material corporate actions. The transaction code "P" confirms an outright purchase; the explanatory footnote clarifies multiple trades at nearly identical prices. From a capital-markets perspective, the size of the purchase is small relative to institutional holdings and does not by itself indicate a material shift in control or ownership.

TL;DR: Governance filing is complete and compliant; disclosure includes per-trade price range.

The Form 4 includes required elements: reporting person identity, relationship to issuer (Director), transaction date, transaction code (P), number of shares acquired, post-transaction beneficial ownership, and an explanatory note about price dispersion. The signature was provided by an attorney-in-fact, which is permissible. No amendments or derivative positions are reported. This appears to be a routine, compliant insider reporting event under Section 16.

Pate R. Carter, amministratore di Option Care Health, Inc. (OPCH), ha comunicato l'acquisto di 750 azioni del capitale sociale della società il 20/08/2025 a un prezzo medio ponderato di $27.1886 per azione. Dopo l'acquisto segnalato, la dichiarazione indica che la persona segnalante detiene beneficiariamente 41.910 azioni. L'operazione è codificata come "P" (acquisto). La nota esplicativa specifica che le 750 azioni sono state acquistate in più operazioni con prezzi compresi tra $27.18 e $27.1899, e che il dichiarante fornirà, su richiesta, le quantità e i prezzi dettagliati per singola transazione. Il Modulo 4 è stato firmato per conto del Sig. Carter da un procuratore.

Pate R. Carter, director de Option Care Health, Inc. (OPCH), informó la compra de 750 acciones de las acciones ordinarias de la compañía el 20/08/2025 a un precio promedio ponderado de $27.1886 por acción. Tras la compra informada, la presentación muestra que la persona informante posee beneficiariamente 41.910 acciones. La operación está codificada como "P" (compra). La nota explicativa indica que las 750 acciones se adquirieron en varias transacciones con precios que oscilan entre $27.18 y $27.1899, y que el informante proporcionará, a petición, las cantidades y precios detallados por operación. El Formulario 4 fue firmado en nombre del Sr. Carter por un apoderado.

Pate R. Carter� Option Care Health, Inc. (OPCH) 이사로서 2025-08-20� 회사 보통� 750�� 주당 가중평� $27.1886� 매수했음� 보고했습니다. 보고� 매수 � 해당 보고인은 41,910�� 실질적으� 보유하고 있는 것으� 기재되어 있습니다. 거래� "P"(매수)� 코드화되� 있습니다. 설명 노트에는 750주가 여러 건의 거래� 매수되었으며 가격은 $27.18에서 $27.1899 사이였�, 요청 � 거래� 수량 � 가격을 상세� 제공하겠다고 명시되어 있습니다. Form 4� 카터 씨를 대신해 법적 대리인� 서명했습니다.

Pate R. Carter, administrateur d'Option Care Health, Inc. (OPCH), a déclaré l'achat de 750 actions ordinaires de la société le 20/08/2025 au prix moyen pondéré de $27.1886 par action. Après l'achat déclaré, le document indique que la personne déclarant détient bénéficiairement 41 910 actions. La transaction est codée "P" (achat). La note explicative précise que les 750 actions ont été acquises en plusieurs opérations aux prix variant de $27.18 à $27.1899, et que le déclarant fournira, sur demande, les quantités et prix détaillés par transaction. Le formulaire 4 a été signé pour M. Carter par un mandataire.

Pate R. Carter, Direktor von Option Care Health, Inc. (OPCH), meldete den Kauf von 750 Aktien der Stammaktien des Unternehmens am 20.08.2025 zu einem gewichteten Durchschnittspreis von $27.1886 je Aktie. Nach dem gemeldeten Erwerb weist die Meldung aus, dass die meldende Person wirtschaftlich 41.910 Aktien besitzt. Die Transaktion ist mit "P" (Kauf) codiert. Die erläuternde Anmerkung besagt, dass die 750 Aktien in mehreren Transaktionen zu Preisen zwischen $27.18 und $27.1899 erworben wurden und der Meldende auf Anfrage detaillierte Mengen und Preise je Trade bereitstellt. Das Formular 4 wurde im Namen von Herrn Carter von einem Bevollmächtigten unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Pate R Carter

(Last) (First) (Middle)
C/O OPTION CARE HEALTH, INC.
3000 LAKESIDE DRIVE, SUITE 300N

(Street)
BANNOCKBURN IL 60015

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Option Care Health, Inc. [ OPCH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/20/2025 P 750 A $27.1886(1) 41,910 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Reflects the weighted average price of 750 shares of common stock of Option Care Health, Inc. purchased by the reporting person in multiple transactions on August 20, 2025 with purchase prices ranging from $27.18 to $27.1899 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
/s/ Michael Shapiro, attorney-in-fact for Mr. Pate 08/21/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did OPCH director Pate R. Carter report purchasing?

The director reported purchasing 750 shares of Option Care Health, Inc. common stock on 08/20/2025.

At what price were the OPCH shares purchased?

The weighted average purchase price was $27.1886 per share; individual trade prices ranged from $27.18 to $27.1899.

How many OPCH shares does the reporting person own after the transaction?

The filing shows the reporting person beneficially owns 41,910 shares following the reported purchase.

What transaction code is used on the Form 4 and what does it mean?

The transaction is coded "P", which denotes an outright purchase of shares.

Who signed the Form 4 for Pate R. Carter?

The Form 4 was signed on behalf of Mr. Carter by Michael Shapiro, attorney-in-fact on 08/21/2025.
Option Care Health Inc

NASDAQ:OPCH

OPCH Rankings

OPCH Latest News

OPCH Latest SEC Filings

OPCH Stock Data

4.66B
161.11M
0.73%
102.01%
3.05%
Medical Care Facilities
Services-home Health Care Services
United States
BANNOCKBURN